
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $782.6M | -- | -- | $4.33 | -- |
07/22/2025 | Q2 | $769.6M | -- | -- | $4.14 | -- |
04/22/2025 | Q1 | $744.5M | $745.8M | $3.71 | $3.90 | -$0.19 |
01/29/2025 | Q4 | $746.7M | $743.5M | $3.90 | $3.95 | -$0.05 |
10/29/2024 | Q3 | $717.7M | $724.7M | $3.57 | $3.77 | -$0.20 |
07/23/2024 | Q2 | $697.5M | $707.9M | $3.37 | $3.55 | -$0.18 |
04/23/2024 | Q1 | $685.9M | $680M | $3.22 | $3.47 | -$0.25 |
01/30/2024 | Q4 | $662.6M | $690.1M | $5.07 | $3.29 | $1.78 |
10/31/2023 | Q3 | -- | -- | $3.27 | $3.31 | -$0.04 |
07/25/2023 | Q2 | -- | -- | $3.09 | $3.11 | -$0.02 |
04/25/2023 | Q1 | -- | -- | $2.97 | $3.00 | -$0.03 |
01/31/2023 | Q4 | -- | -- | $2.67 | $2.76 | -$0.09 |
10/25/2022 | Q3 | -- | -- | $2.68 | $2.71 | -$0.03 |
07/26/2022 | Q2 | -- | -- | $2.59 | $2.67 | -$0.08 |
04/26/2022 | Q1 | -- | -- | $2.78 | $2.79 | -$0.01 |
01/27/2022 | Q4 | -- | -- | $2.32 | $2.49 | -$0.17 |
10/26/2021 | Q3 | -- | -- | $2.03 | $2.43 | -$0.40 |
07/27/2021 | Q2 | -- | -- | $1.99 | $2.31 | -$0.32 |
04/27/2021 | Q1 | -- | -- | $2.36 | $2.26 | $0.10 |
01/28/2021 | Q4 | -- | -- | $1.87 | $1.94 | -$0.07 |
10/27/2020 | Q3 | -- | -- | $2.16 | $1.82 | $0.34 |
07/28/2020 | Q2 | -- | -- | $1.36 | $1.68 | -$0.32 |
04/28/2020 | Q1 | -- | -- | $1.73 | $1.69 | $0.04 |
01/30/2020 | Q4 | -- | -- | $1.44 | $1.61 | -$0.17 |
10/31/2019 | Q3 | -- | -- | $1.60 | $1.59 | $0.01 |
08/01/2019 | Q2 | -- | -- | $1.54 | $1.51 | $0.03 |
05/02/2019 | Q1 | -- | -- | $1.55 | $1.40 | $0.15 |
01/31/2019 | Q4 | -- | -- | $1.31 | $1.30 | $0.01 |
11/01/2018 | Q3 | -- | -- | $1.35 | $1.29 | $0.06 |
08/02/2018 | Q2 | -- | -- | $1.30 | $1.28 | $0.02 |
05/03/2018 | Q1 | -- | -- | $1.31 | $1.26 | $0.05 |
02/01/2018 | Q4 | -- | -- | $1.15 | $1.00 | $0.15 |
11/02/2017 | Q3 | -- | -- | $1.00 | $0.97 | $0.03 |
08/03/2017 | Q2 | -- | -- | $0.95 | $0.90 | $0.05 |
05/04/2017 | Q1 | -- | -- | $0.88 | $0.85 | $0.03 |
02/02/2017 | Q4 | -- | -- | $0.81 | $0.75 | $0.06 |
10/27/2016 | Q3 | -- | -- | $0.77 | $0.73 | $0.04 |
07/28/2016 | Q2 | -- | -- | $0.77 | $0.71 | $0.06 |
04/28/2016 | Q1 | -- | -- | $0.68 | $0.63 | $0.05 |
02/04/2016 | Q4 | -- | -- | $0.66 | $0.59 | $0.07 |
10/29/2015 | Q3 | -- | -- | $0.60 | $0.53 | $0.07 |
MSCI reported $745.8M worth of top line sales in its most recent quarter.
MSCI announced earnings per share of $3.71 which represents a miss of analyst forecast a $3.90 per share.
MSCI reported $609M that represents $7.83 per share over the last quarter.
MSCI's earnings are forecast to grow from $14.05 per share to $15.01 per share next year representing an increase of 19.45%.
MSCI's next earnings date is July 22, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.